Yi-Ling Chen Selected Research

WK175

7/2010

A combination of the metabolic enzyme inhibitor APO866 and the immune adjuvant L-1-methyl tryptophan induces additive antitumor activity.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yi-Ling Chen Research Topics

Disease

34	Neoplasms (Cancer) 01/2022 - 08/2003
31	Inflammation (Inflammations) 01/2022 - 01/2011
16	Ischemia 04/2022 - 11/2012
13	Fibrosis (Cirrhosis) 01/2022 - 01/2014
10	Reperfusion Injury 01/2020 - 09/2015
9	Hypoxia (Hypoxemia) 01/2020 - 11/2012
8	Sepsis (Septicemia) 10/2017 - 04/2008
7	Neoplasm Metastasis (Metastasis) 01/2022 - 01/2015
7	Shock 04/2019 - 01/2014
6	Infections 07/2021 - 10/2008
6	COVID-19 07/2021 - 06/2020
6	Carcinogenesis 01/2021 - 01/2015
6	Stomach Neoplasms (Stomach Cancer) 01/2021 - 10/2011
6	Body Weight (Weight, Body) 01/2020 - 07/2006
5	Infarction (Infarctions) 04/2022 - 08/2015
5	Hepatocellular Carcinoma (Hepatoma) 01/2022 - 10/2011
5	Adenocarcinoma 01/2020 - 01/2015
5	Carcinoma (Carcinomatosis) 04/2015 - 10/2008
4	Heart Failure 04/2022 - 12/2015
4	Chronic Renal Insufficiency 04/2022 - 01/2015
4	Cardio-Renal Syndrome 04/2022 - 11/2016
4	Breast Neoplasms (Breast Cancer) 01/2022 - 10/2016
4	Insulin Resistance 06/2018 - 02/2010
4	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 01/2018 - 04/2008
3	Brain Infarction 07/2021 - 11/2016
3	Pain (Aches) 01/2020 - 09/2014
3	Ischemic Stroke 10/2019 - 02/2016
3	Brain Edema (Cerebral Edema) 01/2019 - 02/2016
3	Lung Injury 01/2018 - 11/2016
3	Bronchopulmonary Dysplasia 04/2008 - 07/2007
2	Diabetic Nephropathies (Diabetic Nephropathy) 01/2022 - 06/2018
2	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2022 - 10/2016
2	Multifocal Choroiditis 07/2021 - 01/2020
2	White Dot Syndromes 07/2021 - 01/2020
2	Stroke (Strokes) 07/2021 - 10/2008
2	Neurodegenerative Diseases (Neurodegenerative Disease) 03/2021 - 12/2016
2	Human Influenza (Influenza) 01/2021 - 01/2010
2	Choroidal Neovascularization 01/2021 - 01/2020
2	Chronic Limb-Threatening Ischemia 10/2020 - 09/2018
2	Birth Weight (Birth Weights) 01/2020 - 08/2012
2	Hypertension (High Blood Pressure) 01/2020 - 01/2016

Drug/Important Bio-Agent (IBA)

42	Proteins (Proteins, Gene)FDA Link 04/2022 - 04/2011
21	Biomarkers (Surrogate Marker)IBA 04/2022 - 10/2011
21	Caspase 3 (Caspase-3)IBA 10/2020 - 11/2012
14	MelatoninIBA 01/2020 - 09/2015
11	salicylhydroxamic acid (SHAM)IBA 09/2018 - 08/2015
10	Cytochromes c (Cytochrome c)IBA 07/2021 - 09/2015
9	Therapeutic UsesIBA 01/2021 - 08/2004
9	Small Interfering RNA (siRNA)IBA 12/2017 - 01/2009
8	CreatinineIBA 04/2022 - 06/2010
8	DNA (Deoxyribonucleic Acid)IBA 04/2022 - 08/2004
8	Messenger RNA (mRNA)IBA 01/2022 - 01/2014
8	Oxygen (Dioxygen)IBA 07/2021 - 08/2009
7	CollagenIBA 01/2019 - 01/2014
7	Matrix Metalloproteinases (MMPs)IBA 01/2019 - 09/2015
6	Exenatide (Byetta)FDA Link 01/2017 - 11/2015
5	CytokinesIBA 07/2021 - 08/2004
5	LipopolysaccharidesIBA 09/2018 - 01/2011
4	Interleukin-6 (Interleukin 6)IBA 07/2021 - 01/2014
4	Pharmaceutical PreparationsIBA 01/2020 - 01/2013
4	EnzymesIBA 01/2020 - 06/2010
4	Doxorubicin (Adriamycin)FDA LinkGeneric 08/2019 - 12/2015
4	AntioxidantsIBA 01/2019 - 02/2014
4	Chemokine CCL5IBA 01/2017 - 01/2014
3	AntigensIBA 01/2022 - 12/2017
3	LipidsIBA 01/2022 - 10/2016
3	Peptides (Polypeptides)IBA 11/2020 - 04/2011
3	Complementary DNA (cDNA)IBA 01/2020 - 01/2015
3	Biological ProductsIBA 01/2020 - 06/2011
3	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 01/2020 - 11/2016
3	Vitamin K 3 (Menadione)FDA Link 09/2018 - 01/2015
3	Triglycerides (Triacylglycerol)IBA 06/2018 - 02/2010
3	Retinol-Binding Proteins (Retinoid Binding Proteins)IBA 01/2018 - 02/2010
3	DNA VaccinesIBA 12/2017 - 08/2004
3	Indicators and Reagents (Reagents)IBA 01/2017 - 11/2015
3	InterleukinsIBA 11/2016 - 12/2014
3	Phosphotransferases (Kinase)IBA 06/2016 - 11/2012
3	LeptinIBA 01/2015 - 02/2010
2	Brain Natriuretic Peptide (Natrecor)FDA Link 04/2022 - 12/2015
2	NitrogenIBA 04/2022 - 01/2018
2	sacubitril and valsartan sodium hydrate drug combinationIBA 04/2022 - 08/2019
2	NPHS2 proteinIBA 01/2022 - 01/2018
2	Estrogen ReceptorsIBA 01/2022 - 01/2020
2	Cyclin D1IBA 01/2022 - 10/2017
2	Reactive Oxygen Species (Oxygen Radicals)IBA 07/2021 - 08/2003
2	TransferasesIBA 03/2021 - 07/2010
2	RNA (Ribonucleic Acid)IBA 01/2021 - 01/2021
2	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 01/2021 - 01/2010
2	Histone Deacetylase InhibitorsIBA 01/2021 - 10/2011
2	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 01/2021 - 01/2020
2	VaccinesIBA 06/2020 - 08/2004
2	ImmunosorbentsIBA 01/2020 - 06/2010
2	Beclin-1IBA 01/2020 - 08/2019

Therapy/Procedure

32	Therapeutics 04/2022 - 01/2009
4	Nephrectomy 01/2022 - 01/2015
4	Length of Stay 07/2021 - 04/2008
4	Ligation 01/2019 - 08/2015
4	Extracorporeal Shockwave Therapy 01/2019 - 01/2014
2	Aftercare (After-Treatment) 02/2021 - 09/2014
2	Transplantation 01/2020 - 02/2013